
Academic Journal
Q2Cellular Reprogramming
About Cellular Reprogramming
Cellular Reprogramming is a scholarly journal published by Mary Ann Liebert Inc.. SCImago 2025 lists it in Q2, with an SJR of 0.553 and H-index of 67.
Coverage: 2010-2026. Research categories: Biotechnology (Q2); Developmental Biology (Q3); Cell Biology (Q4).
Source-backed journal facts
Topics in published research
Pluripotent Stem Cells Research; CRISPR and Genetic Engineering; Reproductive Biology and Fertility; Animal Genetics and Reproduction; Tissue Engineering and Regenerative Medicine; Mesenchymal stem cell research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Ferroptosis-Targeted Strategies to Counter Hypoxia- and Acidosis-Associated Immunosuppression in the Tumor Microenvironment
Wanqiu Zhang, Xiaofei Zhang, Sili Kong, Xiaodong Sun et al.
2026-10-01 · DOI: 10.1177/21524971261493449Reprogramming Stars #30: From Blood Origin to Immunoengineering—An Interview with Dr. Rio Sugimura
Rio Sugimura, Mariana Lopes, Carlos-Filipe Pereira
2026-09-30 · DOI: 10.1177/21524971261494393In Vitro Cellular Dynamics of Skin-Derived Fibroblasts of an MSTN −/− Gene-Edited Buffalo
Anushka Verma, Priyanka Singh, Gaurav Tripathi, Shavi Verma et al.
2026-09-30 · DOI: 10.1177/21524971261492151Zfp462 Regulates the Pluripotency of Embryonic Stem Cells by Cooperating with the Core Transcriptional Network
Meng Yu, Yi Yang, Chunlin Chen, Jiaqi Wang et al.
2026-09-18 · DOI: 10.1177/21524971261489113ROCK Inhibition Accelerates Mesenchymal-to-Epithelial Transition and Improves Early Survival During Human Fibroblast Reprogramming
Mahsa Azhdari, Samaneh Dehghan, Ali Ghamari, Reza Mirshahi et al.
2026-10-01 · DOI: 10.1177/21524971261484998Reprogramming Stars #29: It Takes Muscle: Exploring Myogenic Reprogramming for Regenerative Medicine—An Interview with Dr. Ori Bar-Nur
Ori Bar-Nur, Mariana Lopes, Carlos-Filipe Pereira
2026-10-01 · DOI: 10.1177/21524971261477143Hematopoietic Cell Fate Reprogramming in the Context of Pathological Processes and Translational Opportunities
Branko Cirovic
2026-08-01 · DOI: 10.1177/21524971261464818Reprogramming Stars #28: Stem Cell-Based Approaches to Build Blood Vessels and Liver Tissue—An Interview with Dr. Lay Teng Ang
Lay Teng Ang, Mariana Lopes, Carlos-Filipe Pereira
2026-08-01 · DOI: 10.1177/21524971261449506Liquid–Cell Interactions in the Tumor Microenvironment: Mechanisms, Biomarkers, and Therapeutic Opportunities
Yaou Wang, Kexin Zhang, Yujie Ma, Zhenghui Tian et al.
2026-10-01 · DOI: 10.1177/21524971261453859Isolation of Buffalo ( Bubalus bubalis ) Theca Cells: A Comparison Among Three Protocols
Jun Zhang, Bing Hu, Junming Sun, Yiqiang Ouyang et al.
2026-06-01 · DOI: 10.1177/21524971261449712The Involvement of Gut Microbiota and Their Key Metabolites in Regulating Fetal Development via the Gut–Placental Axis
Hao Zhang, Tingting Ni, Xia Zha, Mabrouk Elsabagh et al.
2026-06-01 · DOI: 10.1177/21524971261450000Reprogramming Stars #27: Drawing Inspiration from Reprogramming to Guide Stem Cell Differentiation: An Interview with Dr. Kyle Loh
Kyle M. Loh, Mariana Lopes, Carlos-Filipe Pereira
2026-06-01 · DOI: 10.1177/21524971261432386Direct Cardiac Reprogramming in the Omics Era: Advances, Mechanisms, and Applications
Chelsea Li, Li Qian
2026-04-01 · DOI: 10.1177/21524971261427184Acknowledgment of Reviewers 2025
2026-02-01 · DOI: 10.1177/21524971251406978Reprogramming Stars #17: Breaking Down the Barriers of Direct Reprogramming Using a Model Organism—An Interview with Dr. Baris Tursun
Baris Tursun, Mariana Lopes, Carlos-Filipe Pereira
2026-02-01 · DOI: 10.1089/cell.2024.54625Reprogramming Stars #16: Reprogramming, from Cells to Embryos—An Interview with Dr. José Silva
José C.R. Silva, Carlos-Filipe Pereira
2026-02-01 · DOI: 10.1089/cell.2024.0041Natural and Artificial Hematopoietic Cell Reprogramming
Dong Yu, Wenpei Liu, Feng Liu, Lin Cheng et al.
2026-02-01 · DOI: 10.1177/21524971261424117Reprogramming Stars #26: Understanding the Reprogramming Privilege—An Interview with Dr. Shangqin Guo
Shangqin Guo, Mariana Lopes, Carlos-Filipe Pereira
2026-04-01 · DOI: 10.1177/21524971251407961In Vitro Generation of Brown and Beige Adipocytes via Cellular Reprogramming
Toshihiro Kurahashi, Yoshinori Harada, Ping Dai
2025-12-01 · DOI: 10.1177/21524971251399164Induction of Neuronal Differentiation of Human Dermal Mesenchymal Stem Cells by a Defined Arginine-Aspartate-Phenylalanine Peptide Mixture in Vitro
Xiaoru Pan, Shengxiu Liu, Rong Zhang, Fengming Yao et al.
2025-12-01 · DOI: 10.1177/21524971251398954Reviews
Community Reviews
Version History
October 4, 2026 at 9:15 pm
October 2, 2026